Biotech Values

[DewDiligence]

FDA approves ABT’s Xience Prime drug-eluting stent:

http://finance.yahoo.com/news/Abbott-Receives-US-FDA-prnews-2224425868.html?x=0&.v=1

XIENCE PRIME, which uses the same drug and biocompatible polymer as the XIENCE V Everolimus Eluting Coronary Stent System, features an enhanced stent design and a delivery system designed for greater flexibility, ideal radial strength, excellent longitudinal strength and more accurate stent placement.

Xience Prime was approved in Europe two years ago (#msg-38985789).